Nifty
:
16352.45
Sensex
:
54884.66
182.30 (1.13%)
632.13 (1.17%)
Nifty
Sensex
:
:
16352.45
54884.66
182.30 (1.13%)
632.13 (1.17%)

Bal Pharma Ltd.

Pharmaceuticals & Drugs

Rating :
51/99

BSE: 524824 | NSE: BALPHARMA

NSE BSE
99.45
27-May-2022
  • Open
  • High
  • Low
  • Previous Close
  •  101.55
  •  104.00
  •  97.50
  •  100.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  17313
  •  17.37
  •  148.85
  •  87.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 156.50
  • 17.20
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 262.67
  • 1.00%
  • 1.79

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 49.57%
  • 0.54%
  • 32.88%
  • FII
  • DII
  • Others
  • 0.31%
  • 0.00%
  • 16.70%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.96
  • 1.82
  • 3.65

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.99
  • 10.73
  • 6.87

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.24
  • 22.05
  • 7.74

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 26.52
  • 30.71
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.85
  • 1.80
  • 1.76

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.58
  • 12.60
  • 13.01

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Net Sales
69.17
63.03
9.74%
67.17
64.56
4.04%
70.83
52.13
35.87%
0.00
33.77
-100.00%
Expenses
62.95
57.10
10.25%
60.85
57.46
5.90%
63.34
47.05
34.62%
0.00
33.14
-100.00%
EBITDA
6.22
5.93
4.89%
6.33
7.10
-10.85%
7.49
5.08
47.44%
0.00
0.63
-100.00%
EBIDTM
8.99%
9.41%
9.42%
11.00%
10.57%
9.75%
0.00%
1.87%
Other Income
0.75
0.19
294.74%
0.56
0.06
833.33%
0.14
0.16
-12.50%
0.00
1.17
-100.00%
Interest
2.36
2.89
-18.34%
2.63
3.19
-17.55%
2.97
2.79
6.45%
0.00
3.02
-100.00%
Depreciation
2.21
2.03
8.87%
2.21
2.17
1.84%
2.19
1.88
16.49%
0.00
3.59
-100.00%
PBT
2.40
1.20
100.00%
2.04
1.81
12.71%
2.46
0.57
331.58%
0.00
-4.80
-
Tax
1.93
0.80
141.25%
0.65
1.31
-50.38%
0.81
0.29
179.31%
0.00
-0.07
-
PAT
0.47
0.40
17.50%
1.40
0.50
180.00%
1.65
0.28
489.29%
0.00
-4.74
-
PATM
0.68%
0.64%
2.08%
0.77%
2.33%
0.54%
0.00%
-14.02%
EPS
0.43
0.22
95.45%
0.93
0.30
210.00%
1.09
0.30
263.33%
0.00
-3.34
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 11
Mar 10
Net Sales
-
250.53
171.09
225.01
209.29
228.91
198.32
187.16
178.87
114.29
106.23
Net Sales Growth
-
46.43%
-23.96%
7.51%
-8.57%
15.42%
5.96%
4.63%
56.51%
7.59%
 
Cost Of Goods Sold
-
140.87
75.74
104.04
88.57
103.94
94.06
87.49
83.74
54.71
55.24
Gross Profit
-
109.66
95.35
120.96
120.71
124.97
104.25
99.67
95.14
59.58
50.99
GP Margin
-
43.77%
55.73%
53.76%
57.68%
54.59%
52.57%
53.25%
53.19%
52.13%
48.00%
Total Expenditure
-
225.88
166.07
207.33
191.95
214.10
183.46
170.05
161.00
104.36
100.95
Power & Fuel Cost
-
4.98
4.76
6.38
6.07
6.17
4.66
4.54
4.39
2.90
2.13
% Of Sales
-
1.99%
2.78%
2.84%
2.90%
2.70%
2.35%
2.43%
2.45%
2.54%
2.01%
Employee Cost
-
41.88
50.44
50.28
52.16
45.37
37.30
32.24
28.12
20.58
19.73
% Of Sales
-
16.72%
29.48%
22.35%
24.92%
19.82%
18.81%
17.23%
15.72%
18.01%
18.57%
Manufacturing Exp.
-
18.61
15.80
20.28
18.03
21.44
19.80
20.78
18.23
11.24
8.90
% Of Sales
-
7.43%
9.23%
9.01%
8.61%
9.37%
9.98%
11.10%
10.19%
9.83%
8.38%
General & Admin Exp.
-
5.45
7.48
9.27
11.21
16.82
13.98
12.43
11.54
5.41
4.71
% Of Sales
-
2.18%
4.37%
4.12%
5.36%
7.35%
7.05%
6.64%
6.45%
4.73%
4.43%
Selling & Distn. Exp.
-
10.27
10.61
15.74
15.63
19.50
13.18
11.91
13.49
8.73
9.62
% Of Sales
-
4.10%
6.20%
7.00%
7.47%
8.52%
6.65%
6.36%
7.54%
7.64%
9.06%
Miscellaneous Exp.
-
3.84
1.23
1.33
0.27
0.86
0.47
0.65
1.48
0.78
9.62
% Of Sales
-
1.53%
0.72%
0.59%
0.13%
0.38%
0.24%
0.35%
0.83%
0.68%
0.58%
EBITDA
-
24.65
5.02
17.68
17.34
14.81
14.86
17.11
17.87
9.93
5.28
EBITDA Margin
-
9.84%
2.93%
7.86%
8.29%
6.47%
7.49%
9.14%
9.99%
8.69%
4.97%
Other Income
-
1.14
1.85
1.01
1.73
3.04
1.28
1.17
0.65
0.79
2.94
Interest
-
12.16
12.73
12.74
9.41
8.49
6.48
6.52
7.16
6.79
6.26
Depreciation
-
9.52
7.68
6.16
6.77
6.49
7.01
7.02
4.74
2.90
2.86
PBT
-
4.10
-13.53
-0.20
2.88
2.87
2.65
4.74
6.63
1.04
-0.91
Tax
-
-0.61
-0.64
-2.36
2.51
3.27
2.39
1.19
1.55
0.63
0.52
Tax Rate
-
-14.88%
4.73%
1180.00%
87.15%
113.94%
90.19%
25.11%
23.38%
60.58%
-57.14%
PAT
-
4.74
-12.22
3.79
2.79
1.75
1.41
3.62
5.07
0.41
-1.43
PAT before Minority Interest
-
4.71
-12.89
2.15
0.38
-0.40
0.26
3.55
5.07
0.41
-1.43
Minority Interest
-
0.03
0.67
1.64
2.41
2.15
1.15
0.07
0.00
0.00
0.00
PAT Margin
-
1.89%
-7.14%
1.68%
1.33%
0.76%
0.71%
1.93%
2.83%
0.36%
-1.35%
PAT Growth
-
-
-
35.84%
59.43%
24.11%
-61.05%
-28.60%
1,136.59%
-
 
EPS
-
3.20
-8.26
2.56
1.89
1.18
0.95
2.45
3.43
0.28
-0.97

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 11
Mar 10
Shareholder's Funds
53.58
52.43
66.64
64.99
62.45
54.90
55.20
50.05
36.18
35.76
Share Capital
14.82
14.17
14.17
14.17
14.17
12.87
12.87
11.11
10.48
10.48
Total Reserves
37.82
38.25
52.47
50.82
48.27
40.01
40.31
37.20
25.50
25.09
Non-Current Liabilities
34.19
33.56
37.85
45.57
30.02
45.12
16.34
17.92
64.54
60.66
Secured Loans
23.93
22.93
28.76
33.25
12.76
15.24
6.11
6.58
53.76
54.41
Unsecured Loans
0.00
0.22
0.00
1.43
5.04
19.71
0.53
1.39
3.97
0.01
Long Term Provisions
4.07
3.62
2.71
2.05
3.42
2.28
1.65
1.06
0.00
0.00
Current Liabilities
152.53
159.49
163.24
154.40
143.24
111.19
92.36
86.77
34.59
27.78
Trade Payables
47.17
38.67
47.34
49.96
54.43
46.85
38.53
33.53
27.02
22.07
Other Current Liabilities
23.57
30.69
27.86
33.77
16.45
12.01
11.86
8.66
6.03
4.73
Short Term Borrowings
80.82
89.63
87.08
68.31
71.07
50.09
40.14
42.75
0.00
0.00
Short Term Provisions
0.98
0.50
0.96
2.37
1.29
2.24
1.83
1.83
1.53
0.99
Total Liabilities
240.07
238.38
261.31
260.17
233.33
211.03
163.87
154.74
135.31
124.20
Net Block
68.59
70.71
70.39
71.48
59.98
56.23
52.20
55.18
54.26
54.98
Gross Block
105.10
97.70
89.76
84.71
66.44
106.10
95.14
90.11
76.86
74.11
Accumulated Depreciation
36.52
27.00
19.37
13.23
6.46
49.87
42.95
34.93
22.60
19.13
Non Current Assets
75.93
81.02
78.26
75.41
68.78
68.03
58.74
59.63
54.40
55.00
Capital Work in Progress
0.00
3.32
3.63
0.21
1.70
3.93
0.77
0.25
0.13
0.00
Non Current Investment
0.00
0.00
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Long Term Loans & Adv.
4.86
5.43
1.69
3.15
6.61
7.54
5.42
3.95
0.00
0.00
Other Non Current Assets
2.49
1.56
2.54
0.55
0.46
0.32
0.34
0.24
0.00
0.00
Current Assets
164.15
157.37
183.05
184.77
164.55
143.00
105.12
95.12
80.90
69.20
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
60.39
67.71
69.75
66.49
54.73
41.75
35.82
31.71
32.21
28.62
Sundry Debtors
67.20
49.60
64.70
64.05
61.80
56.94
44.98
45.49
37.02
31.92
Cash & Bank
3.85
3.13
4.32
4.15
4.71
4.63
5.49
3.02
2.23
1.61
Other Current Assets
32.71
4.07
0.70
0.24
43.31
39.66
18.83
14.89
9.44
7.05
Short Term Loans & Adv.
28.02
32.85
43.58
49.83
42.45
38.45
17.48
13.96
5.56
4.59
Net Current Assets
11.61
-2.12
19.81
30.36
21.31
31.81
12.77
8.35
46.31
41.42
Total Assets
240.08
238.39
261.31
260.18
233.33
211.03
163.86
154.75
135.30
124.20

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 11
Mar 10
Cash From Operating Activity
21.78
23.24
7.76
0.58
6.31
-19.35
14.53
13.31
4.61
-5.22
PBT
4.10
-13.53
-0.20
2.88
2.87
2.65
4.74
6.63
1.04
-0.91
Adjustment
21.14
19.01
17.41
15.14
14.79
11.46
11.69
10.43
9.49
7.12
Changes in Working Capital
-3.35
17.94
-7.07
-16.18
-9.95
-32.66
-0.59
-2.59
-6.10
-10.70
Cash after chg. in Working capital
21.89
23.42
10.13
1.84
7.72
-18.55
15.84
14.47
4.43
-4.48
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-0.11
-0.17
-2.38
-1.27
-1.40
-0.80
-1.31
-1.16
0.18
-0.74
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-4.98
-4.71
-8.04
-3.56
-7.96
-13.88
-5.30
-7.30
-1.59
4.61
Net Fixed Assets
-3.66
-6.22
-4.61
-3.80
41.86
-12.93
-5.24
-15.62
-2.86
-6.26
Net Investments
-0.98
0.02
0.00
-7.42
1.16
-0.09
-1.07
0.04
0.00
0.03
Others
-0.34
1.49
-3.43
7.66
-50.98
-0.86
1.01
8.28
1.27
10.84
Cash from Financing Activity
-16.63
-19.97
0.01
3.53
-5.94
32.37
-6.80
-7.52
-2.40
0.74
Net Cash Inflow / Outflow
0.17
-1.44
-0.27
0.55
-7.58
-0.86
2.43
-1.51
0.62
0.13
Opening Cash & Equivalents
0.86
2.44
2.71
2.16
-17.72
5.49
3.02
4.53
1.61
1.49
Closing Cash & Equivalent
1.02
0.86
2.44
2.71
-25.30
4.63
5.45
3.02
2.23
1.61

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 11
Mar 10
Book Value (Rs.)
35.52
36.99
47.02
45.86
44.06
41.09
41.32
43.48
34.33
33.94
ROA
1.97%
-5.16%
0.83%
0.15%
-0.18%
0.14%
2.23%
3.50%
0.31%
-1.16%
ROE
8.97%
-21.65%
3.27%
0.59%
-0.69%
0.49%
7.00%
12.03%
1.14%
-4.22%
ROCE
9.72%
-0.44%
6.88%
7.45%
7.59%
7.35%
10.88%
14.05%
8.51%
6.31%
Fixed Asset Turnover
2.47
1.83
2.58
2.80
2.72
2.01
2.06
2.18
1.60
1.58
Receivable days
85.08
121.92
104.42
108.60
92.23
91.87
86.58
82.73
104.23
99.58
Inventory Days
93.31
146.63
110.50
104.61
74.94
69.91
64.63
64.10
91.99
85.43
Payable days
111.21
90.28
86.70
99.47
88.16
89.31
79.05
72.93
89.00
77.88
Cash Conversion Cycle
67.18
178.27
128.22
113.74
79.02
72.47
72.17
73.90
107.22
107.13
Total Debt/Equity
2.09
2.26
1.85
1.69
1.49
1.68
0.93
1.08
1.60
1.53
Interest Cover
1.34
-0.06
0.98
1.31
1.34
1.41
1.73
1.93
1.15
0.86

Annual Reports:

FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011
FY 2010

News Update:


  • Acuite upgrades credit ratings of Bal Pharma
    22nd Feb 2022, 12:27 PM

    Long term-Term Loan has been upgraded to ‘BBB-’ stable from ‘BB+’ positive

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.